[ Price : $8.95]
FDA posts a draft guidance entitled Crohns Disease: Developing Drugs for Treatment that discusses clinical trial considerations.[ Price : $8.95]
Federal Register notice: FDA issues a priority review voucher to Gilead Sciences under the agencys material threat medical counter...[ Price : $8.95]
FDA lifts a clinical hold on a Finch Therapeutics Group IND for CP101, an orally administered microbiome therapeutic which is in l...[ Price : $8.95]
FDA announces the tentative Vaccines and Related Biological Products Advisory Committee schedule that has five separate dates the ...[ Price : $8.95]
FDA posts a draft guidance entitled Ulcerative Colitis: Developing Drugs for Treatment.[ Price : $8.95]
FDA sends an email to Praxis Precision Medicines that placed a clinical hold on PRAX-222, an antisense oligonucleotide for treatin...[ Price : $8.95]
FDA warns healthcare providers about the possibility that patients who have Medtronics Heartware Ventricular Assist Device System ...[ Price : $8.95]
CDERs Office of Compliance (OC) says its priorities for 2022 include supporting FDAs Covid-19 response , reducing harm caused by o...